Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease

Hypertension

Volumn 65, Issue 1, 2015, Pages 200-210

  Gopalakrishnan, Kathirvel ^a   Kumarasamy, Sivarajan ^a   Mell, Blair ^a   Joe, Bina ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Blood Pressure; Inbred Dahl; Inbred Shr; Rats; Rna Untranslated; Transcriptome

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASB3 GENE; CARDIOVASCULAR DISEASE; CHAC2 GENE; COMPARATIVE STUDY; DAHL SALT RESISTANT RAT; DAHL SALT SENSITIVE RAT; GENE; GENE TARGETING; GENETIC ASSOCIATION; KIDNEY DISEASE; NONHUMAN; PEX11B GENE; PROTEIN EXPRESSION; RAT; RAT STRAIN; RNA ANALYSIS; RNA SEQUENCE; RNA TRANSCRIPTION; SP5 GENE; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOBLOTTING; KIDNEY DISEASES; MICROARRAY ANALYSIS; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; IMMUNOBLOTTING; KIDNEY DISEASES; MICROARRAY ANALYSIS; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RNA, LONG NONCODING;

EID: 84919451802     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04498     Document Type: Article

References (53)

1. Sur I, Tuupanen S, Whitington T, Aaltonen LA, Taipale J. Lessons from functional analysis of genome-wide association studies. Cancer Res. 2013;73:4180-4184.
2. Koch L. Disease genetics: insights into missing heritability. Nat Rev Genet. 2014;15:218.
3. Hrdlickova B, de Almeida RC, Borek Z, Withoff S. Genetic variation in the noncoding genome: Involvement of micro-RNAs and long noncoding RNAs in disease. Biochim Biophys Acta. 2014;1842:1910-1922.
4. van Duijvenboden K, Ruijter JM, Christoffels VM. Gene regulatory elements of the cardiac conduction system. Brief Funct Genomics. 2014;13:28-38.
5. Gopalakrishnan K, Saikumar J, Peters CG, Kumarasamy S, Farms P, Yerga-Woolwine S, Toland EJ, Schnackel W, Giovannucci DR, Joe B. Defining a rat blood pressure quantitative trait locus to a <81.8 kb congenic segment: comprehensive sequencing and renal transcriptome analysis, Physiol Genomics, 2010, 42, 153-161
6. Pillai R, Waghulde H, Nie Y, Gopalakrishnan K, Kumarasamy S, Farms P, Garrett MR, Atanur SS, Maratou K, Aitman TJ, Joe B. Isolation and high-throughput sequencing of two closely linked epistatic hypertension susceptibility loci with a panel of bicongenic strains. Physiol Genomics. 2013;45:729-736.
7. Atanur SS, Diaz AG, Maratou K, et al. Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat. Cell. 2013;154:691-703.
8. Loscalzo J, Handy DE. Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm Circ. 2014;4:169-174.
9. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011;123:2145-2156.
10. Liang M, Cowley AW Jr, Mattson DL, Kotchen TA, Liu Y. Epigenomics of hypertension. Semin Nephrol. 2013;33:392-399.
11. El Shamieh S, Visvikis-Siest S. Genetic biomarkers of hypertension and future challenges integrating epigenomics. Clin Chim Acta. 2012;414:259-265.
12. Fornage M. Unraveling hypertension: epigenomics comes of age. Pharmacogenomics. 2007;8:125-128.
13. Fornage M, Doris PA. Genomics and epigenomics of hypertension. Curr Opin Mol Ther. 2006;8:206-214.
14. Kriegel AJ, Mladinov D, Liang M. Translational study of microRNAs and its application in kidney disease and hypertension research. Clin Sci (Lond). 2012;122:439-447.
15. Perkel JM. Visiting noncodarnia. Biotechniques. 2013;54:301, 303- 301, 304.
16. Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10:925-933.
17. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354-361.
18. Bernstein E, Allis CD. RNA meets chromatin. Genes Dev. 2005;19:1635-1655.
19. Whitehead J, Pandey GK, Kanduri C. Regulation of the mammalian epigenome by long noncoding RNAs. Biochim Biophys Acta. 2009;1790:936-947.
20. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904-914.
21. Johnsson P, Morris KV. Expanding the functional role of long noncoding RNAs [published online ahead of print August 8, 2014]. Cell Res. doi: 10.1038/cr.2014.104. http://www.nature.com/cr/journal/vaop/ncurrent/full/cr2014104a.html. Accessed October 29, 2014.
22. Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014;157:77-94.
23. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, Regev A, Lander ES, Rinn JL. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106:11667-11672.
24. Yang L, Lin C, Rosenfeld MG. A lincRNA switch for embryonic stem cell fate. Cell Res. 2011;21:1646-1648.
25. Parker BJ, Moltke I, Roth A, Washietl S, Wen J, Kellis M, Breaker R, Pedersen JS. New families of human regulatory RNA structures identified by comparative analysis of vertebrate genomes. Genome Res. 2011;21:1929-1943.
26. Guttman M, Donaghey J, Carey BW, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477: 295-300.
27. Guttman M, Garber M, Levin JZ, Donaghey J, Robinson J, Adiconis X, Fan L, Koziol MJ, Gnirke A, Nusbaum C, Rinn JL, Lander ES, Regev A. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol. 2010;28:503-510.
28. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458:223-227.
29. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915-1927.
30. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071-1076.
31. Leung A, Trac C, Jin W, Lanting L, Akbany A, Strom P, Schones DE, Natarajan R. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res. 2013;113:266-278.
32. Matkovich SJ, Edwards JR, Grossenheider TC, de Guzman Strong C, Dorn GW 2nd. Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc Natl Acad Sci U S A. 2014;111:12264-12269.
33. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775-1789.
34. Ravasi T, Suzuki H, Pang KC, Katayama S, Furuno M, Okunishi R, Fukuda S, Ru K, Frith MC, Gongora MM, Grimmond SM, Hume DA, Hayashizaki Y, Mattick JS. Experimental validation of the regulated expression of large numbers of noncoding RNAs from the mouse genome. Genome Res. 2006;16:11-19.
35. Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell. 2011;147:1537-1550.
36. Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26-46.
37. Clark MB, Johnston RL, Inostroza-Ponta M, Fox AH, Fortini E, Moscato P, Dinger ME, Mattick JS. Genome-wide analysis of long noncoding RNA stability. Genome Res. 2012;22:885-898.
38. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev. 2000;80:135-172.
39. Garrett MR, Dene H, Rapp JP. Time-course genetic analysis of albuminuria in Dahl salt-sensitive rats on low-salt diet. J Am Soc Nephrol. 2003;14:1175-1187.
40. Garrett MR, Saad Y, Dene H, Rapp JP. Blood pressure QTL that differentiate Dahl salt-sensitive and spontaneously hypertensive rats. Physiol Genomics. 2000;3:33-38.
41. Garrett MR, Pezzolesi MG, Korstanje R. Integrating human and rodent data to identify the genetic factors involved in chronic kidney disease. J Am Soc Nephrol. 2010;21:398-405.
42. Arnett DK, Meyers KJ, Devereux RB, Tiwari HK, Gu CC, Vaughan LK, Perry RT, Patki A, Claas SA, Sun YV, Broeckel U, Kardia SL. Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families. Circ Res. 2011;108:279-283.
43. Bragg-Gresham JL. Genetic insights into aging and age-related diseases among varied pedigree structures. 2013;Doctor of Philosophy. http://deepblue. lib.umich.edu/bitstream/handle/2027.42/97920/jennb-1.pdf?sequence=1. Published online December 6, 2013. Accessed October 29, 2014.
44. Fujita T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension. 2010;55:813-818.
45. Channa ML, Somova L, Nadar A. Facets of the metabolic syndrome in Dahl hypertensive rats. Cardiovasc J S Afr. 2004;15:61-63.
46. Somova L, Channa ML. Glucose metabolism and insulin sensitivity in Dahl hypertensive rats. Methods Find Exp Clin Pharmacol. 1999;21:421-425.
47. Shimamoto K, Ura N. Mechanisms of insulin resistance in hypertensive rats. Clin Exp Hypertens. 2006;28:543-552.
48. Pravenec M, Kurtz TW. Genetics of Cd36 and the hypertension metabolic syndrome. Semin Nephrol. 2002;22:148-153.
49. Pravenec M, Zidek V, Simakova M, et al. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest. 1999;103:1651-1657.
50. Aitman TJ, Gotoda T, Evans AL, et al. Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet. 1997;16:197-201.
51. Morrissey C, Grieve IC, Heinig M, Atanur S, Petretto E, Pravenec M, Hubner N, Aitman TJ. Integrated genomic approaches to identification of candidate genes underlying metabolic and cardiovascular phenotypes in the spontaneously hypertensive rat. Physiol Genomics. 2011;43:1207-1218.
52. Basile KJ, Johnson ME, Xia Q, Grant SF. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies. Int J Endocrinol. 2014;2014:769671.
53. Boj SF, van Es JH, Huch M, Li VS, Jos A, Hatzis P, Mokry M, Haegebarth A, van den Born M, Chambon P, Voshol P, Dor Y, Cuppen E, Fillat C, Clevers H. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell. 2012;151:1595-1607.